Nuritas Secures $42 Million Series C Funding Led by M&G Investments to Advance AI-Driven Peptide Discovery Platform

Investment Circle (ID: pedaily2012) December 27th, by reporter, Nuritas, a biotechnology company, recently announced the completion of$42 million in Series C financing,ByM&G Investments Leads the Investment，McWinCapital Partners participated in the support, with existing investors Grosvenor and ECBF continuing to participate.. This round of financingThe funds will be used to further enhance its AI-based plant ingredient discovery platform.For AI-driven peptide innovation to improve the lives of billions.

Nuritas, founded by Dr. Nora Khaldi in 2014, is dedicated to combining the strengths of information technology and life sciences, using artificial intelligence to accelerate the identification of bioactive molecules—peptides—that are difficult to discover in plants. The company's developed Magnifier platform can identify peptide molecules 10 to 50 times faster than traditional methods, bringing significant potential to the health food industry.

This financing will help Nuritas expand its operations and further extend its global customer base. Alex Seddon from M&G Investments and Henry McGovern from McWin Capital Partners will join the Nuritas board to support the company in exploring more market opportunities. Seddon stated that Nuritas' work in driving food ingredient discovery through artificial intelligence will have a positive impact on global health and promote the achievement of health outcomes.